These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9419523)

  • 21. Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.
    Schnorr J; Wagner S; Abramjuk C; Drees R; Schink T; Schellenberger EA; Pilgrimm H; Hamm B; Taupitz M
    Radiology; 2006 Jul; 240(1):90-100. PubMed ID: 16684917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of gadolinium Cy2DOTA, a new hepatobiliary agent, and gadolinium HP-DO3A, an extracellular agent, in healthy liver and metastatic disease.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1995 Feb; 30(2):123-30. PubMed ID: 7782188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT and MR imaging of the liver using liver-specific contrast media. A comparative study in a tumour model.
    Leander P; Månsson S; Ege T; Besjakov J
    Acta Radiol; 1996 May; 37(3 Pt 1):242-9. PubMed ID: 8845249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice.
    Ogan MD; Revel D; Brasch RC
    Invest Radiol; 1987 Oct; 22(10):822-8. PubMed ID: 3429177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. A correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization.
    Ni Y; Marchal G; Zhang X; Van Hecke P; Michiels J; Yu J; Rummeny E; Lodemann KP; Baert AL
    Invest Radiol; 1993 Jun; 28(6):520-8. PubMed ID: 8320070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic tumor detection: MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase.
    Forsberg F; Piccoli CW; Liu JB; Rawool NM; Merton DA; Mitchell DG; Goldberg BB
    Radiology; 2002 Mar; 222(3):824-9. PubMed ID: 11867808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, characterization, and imaging performance of a new class of macrocyclic hepatobiliary MR contrast agents.
    Marinelli ER; Neubeck R; Song B; Wagler T; Ranganathan RS; Sukumaran K; Wedeking PW; Nunn A; Runge VM; Tweedle MF
    Invest Radiol; 2000 Jan; 35(1):8-24. PubMed ID: 10639032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mn(2+)-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T1-weighted MRI.
    Kim SM; Im GH; Lee DG; Lee JH; Lee WJ; Lee IS
    Biomaterials; 2013 Nov; 34(35):8941-8. PubMed ID: 23973173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
    Kuo YT; Chen CY; Liu GC; Wang YM
    PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study.
    Ni Y; Marchal G; Yu J; Rummeny E; Zhang X; Lodemann KP; Baert AL
    Radiology; 1993 Jul; 188(1):45-51. PubMed ID: 8390071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology.
    Marchal G; Zhang X; Ni Y; Van Hecke P; Yu J; Baert AL
    Magn Reson Imaging; 1993; 11(5):665-74. PubMed ID: 8345781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver-specific contrast media for MRI and CT experimental studies.
    Leander P
    Acta Radiol Suppl; 1995; 396():1-36. PubMed ID: 7839867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR imaging assessment of experimental hepatic dysfunction with Mn-DPDP.
    Coley BD; Mattrey RF; Baker KG; Peterson T; Burgan AR
    J Magn Reson Imaging; 1995; 5(1):11-6. PubMed ID: 7696800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposome encapsulated MnCl2 as a liver specific contrast agent for magnetic resonance imaging.
    Niesman MR; Bacic GG; Wright SM; Swartz HJ; Magin RL
    Invest Radiol; 1990 May; 25(5):545-51. PubMed ID: 2345086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positron Emission Tomography-Magnetic Resonance Imaging Pharmacokinetics, In Vivo Biodistribution, and Whole-Body Elimination of Mn-PyC3A.
    Zhou IY; Ramsay IA; Ay I; Pantazopoulos P; Rotile NJ; Wong A; Caravan P; Gale EM
    Invest Radiol; 2021 Apr; 56(4):261-270. PubMed ID: 33136686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal metastasis. Detection and characterization on enhanced magnetic resonance imaging using an animal model.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1997 Apr; 32(4):212-7. PubMed ID: 9101356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging of experimental pyelonephritis in rabbits.
    Runge VM; Timoney JF; Williams NM
    Invest Radiol; 1997 Nov; 32(11):696-704. PubMed ID: 9387058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR and CT imaging of ethanol-treated liver tumors in an animal model.
    Phillips JJ; Chang SL; Vargas HI; Dickman PS; Butler JA; Lipcamon JD
    Magn Reson Imaging; 1991; 9(2):201-4. PubMed ID: 2034053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.